137 related articles for article (PubMed ID: 30082079)
21. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.
Autore F; Innocenti I; Luigetti M; Piccirillo N; Sora F; Chiusolo P; Sica S; Bacigalupo A; Laurenti L
Hematol Oncol; 2018 Apr; 36(2):392-398. PubMed ID: 28913957
[TBL] [Abstract][Full Text] [Related]
22. [POEMS syndrome with increased vascular endothelial growth factor (VEGF) and multiple osteosclerotic lesion].
Katayama M; Wada T; Nagai K; Takechi H; Wakatsuki Y; Kita T; Fukatsu A; Yamada Y
Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1864-6. PubMed ID: 12170754
[No Abstract] [Full Text] [Related]
23. Relapse of POEMS syndrome without increased level of VEGF.
Kuwabara S; Kanai K; Misawa S; Nakaseko C
Neuromuscul Disord; 2009 Oct; 19(10):740; author reply 740-1. PubMed ID: 19720532
[No Abstract] [Full Text] [Related]
24. Glomeruloid haemangioma: a possible consequence of elevated VEGF in POEMS and Erdheim-Chester disease.
Legendre P; Norkowski E; Le Pelletier F; Miyara M; Choquet S; Haroche J; Brocheriou I; Barete S
Eur J Dermatol; 2018 Dec; 28(6):784-789. PubMed ID: 30563806
[TBL] [Abstract][Full Text] [Related]
25. Increased serum level of vascular endothelial growth factor in Crow-Fukase syndrome.
Yamamoto T; Kuroda M; Nishioka K
Acta Derm Venereol; 2001; 81(4):317-8. PubMed ID: 11720194
[No Abstract] [Full Text] [Related]
26. POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.
Isose S; Misawa S; Kanai K; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Nakaseko C; Kuwabara S
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):678-80. PubMed ID: 20562460
[TBL] [Abstract][Full Text] [Related]
27. No nephropathy in Type 2 diabetic patient with POEMS syndrome with an elevated plasma VEGF.
Baba T; Ăsterby R; Neugebauer-Baba S; Nozawa Y; Watanabe T; Sakurai K; Katoh T; Watanabe T
Diabet Med; 2004 Mar; 21(3):292-4. PubMed ID: 15008843
[TBL] [Abstract][Full Text] [Related]
28. Lenalidomide therapy in a patient with POEMS syndrome.
Dispenzieri A; Klein CJ; Mauermann ML
Blood; 2007 Aug; 110(3):1075-6. PubMed ID: 17644745
[No Abstract] [Full Text] [Related]
29. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome.
Kanai K; Sawai S; Sogawa K; Mori M; Misawa S; Shibuya K; Isose S; Fujimaki Y; Noto Y; Sekiguchi Y; Nasu S; Nakaseko C; Takano S; Yoshitomi H; Miyazaki M; Nomura F; Kuwabara S
Neurology; 2012 Aug; 79(6):575-82. PubMed ID: 22843279
[TBL] [Abstract][Full Text] [Related]
30. Recurrent Crow-Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: a case report and review of the literature.
Mineta M; Hatori M; Sano H; Hosaka M; Kokubun S; Hiroki E; Hatakeyama A; Ogasawara T
Tohoku J Exp Med; 2006 Nov; 210(3):269-77. PubMed ID: 17077605
[TBL] [Abstract][Full Text] [Related]
31. Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMSÂ syndrome.
Bianco M; Terenghi F; Gallia F; Nozza A; Scarale A; Fayoumi MZ; Giannotta C; Nobile-Orazio E
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):367-368. PubMed ID: 29945880
[No Abstract] [Full Text] [Related]
32. POEMS syndrome: importance of the clinical laboratory practitioner's role.
Levinson SS
Clin Chim Acta; 2012 Nov; 413(21-22):1800-7. PubMed ID: 22771968
[TBL] [Abstract][Full Text] [Related]
33. Osteolytic lesion with thick sclerotic walls and demyelinating polyneuropathy.
Forestier A; Lefebvre G; Leroy X; Husson J; Gay J; Leleu X; Hachulla E; Hatron PY; Launay D
J Rheumatol; 2012 Nov; 39(11):2175-6. PubMed ID: 23118279
[No Abstract] [Full Text] [Related]
34. Vascular endothelial growth factor and POEMS.
Dyck PJ; Engelstad J; Dispenzieri A
Neurology; 2006 Jan; 66(1):10-2. PubMed ID: 16401837
[No Abstract] [Full Text] [Related]
35. Revealing serum lipidomic characteristics and potential lipid biomarkers in patients with POEMS syndrome.
Zhao H; Gao XM; Cao XX; Zhang L; Zhou DB; Li J
J Cell Mol Med; 2021 May; 25(9):4307-4315. PubMed ID: 33779058
[TBL] [Abstract][Full Text] [Related]
36. Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation.
Goto H; Nishio M; Kumano K; Fujimoto K; Yamaguchi K; Koike T
Bone Marrow Transplant; 2008 Nov; 42(9):627-9. PubMed ID: 18660839
[No Abstract] [Full Text] [Related]
37. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
Briani C; Dalla Torre C; Lessi F; Cavallaro T; Scarlato M; Ferrari S; Campagnolo M; Lucchetta M; Cabrini I; Morbin M; Lauria G; Adami F; Manfredi AA
J Neuroimmunol; 2014 Dec; 277(1-2):189-92. PubMed ID: 25447599
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
[TBL] [Abstract][Full Text] [Related]
39. POEMS Syndrome: Diagnosis and Investigative Work-up.
Dispenzieri A; Kourelis T; Buadi F
Hematol Oncol Clin North Am; 2018 Feb; 32(1):119-139. PubMed ID: 29157614
[TBL] [Abstract][Full Text] [Related]
40. [A POEMS syndrome revealed by a blue toe syndrome].
Decker P; Galland J; Risse J; Claudin M; Mohamed S; Perrot A; Wahl D
Rev Med Interne; 2018 Feb; 39(2):127-129. PubMed ID: 29288001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
